Investigators in the FAVOR II China and FAVOR II Europe-Japan studies recently presented their results at the 2017 Transcatheter Cardiovascular Therapeutics (TCT) annual conference, Oct. 29-Nov. 2 in Denver.

http://www.tctconference.comA new study has found that a pioneering device to repair heart valves is safe and effective, and can reduce the invasiveness and side effects of conventional mitral valve surgery. The Harpoon Mitral Valve Repair System (H-MVRS), an image-guided device based on technology developed at the University of Maryland School of Medicine (UMSOM), is deployed through a small opening between the ribs, and repairs the heart while it continues to beat. The research was presented at the Transcatheter Cardiovascular Therapeutics (TCT 2017) symposium, Oct. 29-Nov. 2 in Denver, and simultaneously published in the Journal of the American College of Cardiology (JACC).

November 6, 2017 — In the Hybrid REvascularization Versus Standards (HREVS) study that evaluated three different ...